Skip to main content
Clinical Trials/KCT0009675
KCT0009675
Recruiting
未知

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Asan Medical Center0 sites122 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Asan Medical Center
Enrollment
122
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Among study subjects requiring gastro\-duodenal endoscopy or endoscopic ultrasound or endoscopic retrograde biliary pancreatic angiography for medical purposes
  • Pancreatic cancer should be in both 1 and 2, 3 or 4\.
  • The control group, which is not pancreatic cancer, should be in both 1 and 2, 5 or 6\.
  • ?Be at least 19 years old
  • ?Receipt of consent for gastro\-duodenal endoscopy or endoscopic ultrasound or endoscopic retrograde biliary pancreatic procedure prior to duodenal fluid inhalation patient
  • ?Biopsy proven pancreatic ductal adenocarcinoma (PDAC) with stage I\-IV
  • ?Suspected pancreatic cancer on imaging and scheduled for endoscopic ultrasound\-guided pancreatic biopsy patient
  • ?Patient with pancreatic cystic tumors or patient with pancreatitis (acute or chronic)
  • ?No pancreatic disease patient

Exclusion Criteria

  • Pancreatic cancer and non\-pancreatic cancer control groups must not meet all of the items 1 to 3 to be eligible for enrollment.
  • ?Hemodynamically unstable for endoscopy to be performed
  • ?If there is a large amount of ascites that is not controlled to perform endoscopy
  • ?If you have a coagulation disorder that cannot be corrected for endoscopy

Outcomes

Primary Outcomes

Not specified

Similar Trials